Wesley Bhatt

Dr. Wesley Bhatt is a computational drug design scientist who applies physics-based molecular modeling including free energy perturbation (FEP+) and docking to optimize cancer therapeutics. His work at Schrödinger has contributed to structure-based optimization of kinase inhibitors and KRAS-targeted compounds. He integrates machine learning with physics-based simulations to accelerate hit-to-lead and lead optimization campaigns in oncology drug discovery.